The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Association of apolipoprotein E ϵ2 and vasculopathy in cerebral amyloid angiopathy
Abstract
Objective Hemorrhage related to cerebral amyloid angiopathy (CAA) appears to occur through a multistep pathway that includes deposition of beta-amyloid in cerebral vessels and specific vasculopathic changes in the amyloid-laden vessels, such as cracking of the vessel wall. Recent reports suggest a positive association between CAA-related hemorrhage and both the apolipoprotein E (APOE) epsilon4 allele and, unexpectedly, the APOE epsilon2 allele. Unlike APOE epsilon4, APOE epsilon2 does not appear to act through increased beta-amyloid deposition. We therefore sought to determine whether it might specifically accelerate the second step in this pathway, that is, development of the vasculopathic changes that lead to hemorrhage. Methods To determine the role of APOE in development of vasculopathic changes, we compared APOE genotypes in two groups of postmortem brains: 52 brains with complete amyloid replacement of vessel walls but without vasculopathic changes, and 23 brains with complete amyloid replacement of vessels with the accompanying changes of cracking of the vessel wall and paravascular leaking of blood. Results Frequency of APOE epsilon2 was significantly greater in the group with vasculopathy (0.09) than the group without (0.01, p = 0.03). The groups did not differ in mean age or extent of neuritic plaques. Analysis of a clinical series of patients with CAA-related hemorrhage confirmed an overrepresentation of APOE epsilon2 as well as an association between this allele a…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, human studies have linked APOE2 to greater CAA severity in some cohorts 52 , and to CAA-related vasculopathic changes and hemorrhagic complications 53,54 .”
From APOE2 attenuates APOE4-associated amyloid pathology and related toxicity in a mouse model of Alzheimer’s disease (2026) · cites this paper as [53]
In the citing paper
“Of note, APOEε2/ε4 individuals have a particularly high risk of intracerebral lobar haemorrhage in the presence of CAA50, possibly because the APOEε2 allele has been associated with fibrinoid necrosis of the vessel wall56,57.”
From Multifaceted roles of APOE in Alzheimer disease (2024) · cites this paper as [56]
Citations
Cites
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., Golbe, L. I., Grafman, J., Growdon, J. H., et al. (1996) · Neurology · doi:10.1212/wnl.47.1.1 · Cited by 2,538
Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9649 · Cited by 1,525
Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study
Vonsattel, J. P. G., Myers, R. H., Tessa Hedley‐Whyte, E., Ropper, A. H., Bird, E. D., & Richardson, E. P. (1991) · Annals of Neurology · doi:10.1002/ana.410300503 · Cited by 662
Self-citationSuarez, F. L., Savaiano, D. A., & Levitt, M. D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507063330101 · Cited by 508
Miller, D. H., Albert, P. S., Barkhof, F., Francis, G., Frank, J. A., Hodgkinson, S., Lublin, F. D., Paty, D. W., Reingold, S. C., & Simon, J. (1996) · Annals of Neurology · doi:10.1002/ana.410390104 · Cited by 444
Neurosurgical horizons in Parkinson's disease
Goetz, C. G., Long, M. R. D., Penn, R. D., & Bakay, R. A. E. (1993) · Neurology · doi:10.1212/wnl.43.1_part_1.1 · Cited by 405
Factors That Predict the Bleeding Risk of Cerebral Arteriovenous Malformations
Pollock, B. E., Flíckinger, J. C., Lunsford, L. D., Bissonette, D. J., & Kondziolka, D. S. (1996) · Stroke · doi:10.1161/01.str.27.1.1 · Cited by 367
Evans, K. C., Berger, E. P., Cho, C. G., Weisgraber, K. H., & Lansbury, P. T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.763 · Cited by 333
Autosomal dominant cerebellar phenotypes
Rosenberg, R. N. (1990) · Neurology · doi:10.1212/wnl.45.1.1 · Cited by 315
Research works printed but not linked: 14
- Vinters HV. Cerebral amyloid angiopathy. A critical review. Stroke 1987;18:311-324.
- Mandybur TI. Cerebral amyloid angiopathy: the vascular pathology and complications. J Neuropathol Exp Neurol 1986;45:79-90.
- Greenberg SM, Hyman BT. Cerebral amyloid angiopathy and apolipoprotein E: bad news for the good allele? Ann Neurol 1997;41:701-702.
- Mayeux R, Stern Y, Ottman R, et al. The apolipoproteinϵ 4 allele in patients with Alzheimer's disease. Ann Neurol 1993;34:752-754.
- Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN. Apolipoprotein E ϵ 4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol 1996;148:2083-2095.
- Lippa CF, Smith TW, Saunders AM, Hulette C, Pulaski Salo D, Roses AD. Apolipoprotein E ϵ 2 and Alzheimer's disease: genotype influences pathologic phenotype. Neurology 1997;48:515-519.
- Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
- Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 1994;13:45-53.
- Alonzo NC, Hyman BT, Rebeck GW, Greenberg SM. Preferential deposition of Aβ40 in parenchymal versus leptomeningeal vessels in cerebral amyloid angiopathy. Neurology 1997;48:A102-A103. Abstract.
- Prelli F, Castano E, Glenner GG, Frangione B. Differences between vascular and plaque core amyloid in Alzheimer's disease. J Neurochem 1988;51:648-651.
- Gravina SA, Ho LB, Eckman CB, et al. Amyloid beta protein (a-beta) in Alzheimer's disease brain-biochemical and immunocytochemical analysis with antibodies specific for forms ending at a-beta-40 or a-beta-42(43). J Biol Chem 1995;270:7013-7016.
- Davis-Salinas J, Van Nostrand WE. Amyloid beta-protein aggregation nullifies its pathologic properties in cultured cerebrovascular smooth muscle cells. J Biol Chem 1995;270:20887-20890.
- Yamaguchi H, Ishiguro K, Sugihara S, et al. Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer beta-amyloid deposition. Acta Neuropathol 1994;88:413-419.
- Ma J, Yee A, Brewer HBJ, Das S, Potter H. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 1994;372:92-94.
Cited by
Sorted by citations
Items 101–200 of 269
Schwab, P., Lidov, H. G. W., Schwartz, R. B., & Anderson, R. J. (2003) · Arthritis Care & Research · doi:10.1002/art.11049 · Cited by 43
Cerebral amyloidal angiopathy—A disease with implications for neurology and psychiatry
Gahr, M., Nowak, D. A., Connemann, B. J., & Schönfeldt‐Lecuona, C. (2013) · Brain Research · doi:10.1016/j.brainres.2013.04.052 · Cited by 43
“…to show that the ε2 allele favours the CAA-related vascular deterioration (splitting of vascular walls, minor haemorrhaging and fibrinoid necrosis) (Greenberg et al., 1998; McCarron et al., 1999), while the ε4 allele is associated with an increased vascular deposition of Aβ (Greenberg et al.,…”
Brouwers, H. B., Biffi, A., McNamara, K. A., Ayres, A. M., Valant, V., Schwab, K. M., Romero, J. M., Viswanathan, A., Greenberg, S. M., Rosand, J. M., et al. (2012) · Stroke · doi:10.1161/strokeaha.112.659094 · Cited by 42
Self-citationCerebral amyloid angiopathy: Review of clinico‐radiological features and mimics
Sharma, R., Dearaugo, S., Infeld, B., O’Sullivan, R., & Gerraty, R. P. (2018) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/1754-9485.12726 · Cited by 44
“Having a personal history of ICH recurrence or possession of the APOE e2 and APOE e4 alleles have all been shown to independently increase the risk of future CAA-related lobar ICH recurrence.(25,35) Furthermore, presence of other clinicoradiological features or use of antiplatelet or anticoagulant therapies may also i…”
BackgroundAnti-Aβ Antibodies and Cerebral Amyloid Angiopathy Complications
Chantran, Y., Capron, J., Alamowitch, S., & Aucouturier, P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01534 · Cited by 42
Plasma β‐Amyloid Peptide, Transforming Growth Factor‐β1, and Risk for Cerebral Amyloid Angiopathy
Greenberg, S. M., CHO, H., O’Donnell, H. C., Rosand, J. M., Segal, A. Z., Younkin, L. H., Younkin, S. G., & Rebeck, G. W. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06361.x · Cited by 42
Self-citationIntracerebral hemorrhage: update
Labovitz, D., & Sacco, R. L. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200102000-00016 · Cited by 41
Complement C1Q polymorphisms modulate onset in familial amyloidotic polyneuropathy TTR Val30Met
Dardiotis, E., Koutsou, P., Zamba‐Papanicolaou, E., Vonta, F., Hadjivassiliou, M., Hadjigeorgiou, G. M., Cariolou, M. A., Christodoulou, K., & Kyriakides, T. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.05.018 · Cited by 40
“However, the ε2 allele has been associated with exacerbation of vasculopathic changes and rupture in cerebral amyloid angiopathy [37].”
BackgroundHaley, K. E., Greenberg, S. M., & Gurol, M. E. (2013) · Current Cardiology Reports · doi:10.1007/s11886-013-0425-8 · Cited by 40
Self-citationMulder, M., & Terwel, D. (1998) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022429 · Cited by 40
Hippocampal sulcal cavities on MRI: Relationship to age and apolipoprotein E genotype
Barboriak, D. P., Doraiswamy, P. M., Krishnan, K., Vidyarthi, S., Sylvester, J., & Charles, H. C. (2000) · Neurology · doi:10.1212/wnl.54.11.2150 · Cited by 39
Lobar Intracerebral Hemorrhage
Sacco, R. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001273420410 · Cited by 38
Association of Apolipoprotein E ε2 With White Matter Disease but Not With Microbleeds
Lemmens, R., Görner, A., Schrooten, M., & Thijs, V. (2007) · Stroke · doi:10.1161/01.str.0000259816.31370.44 · Cited by 37
Smith, E. E., Rosand, J. M., & Greenberg, S. M. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.05.003 · Cited by 36
Self-citationAPOE ɛ 2 is associated with white matter hyperintensity volume in CADASIL
Gesierich, B. G., Opherk, C., Rosand, J. M., Gonik, M., Malik, R., Jouvent, É., Hervé, D., Adib‐Samii, P., Bevan, S., Pianese, L., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.85 · Cited by 35
FGF-2 overexpression opposes the beta amyloid toxic injuries to the vascular endothelium
Donnini, S., Cantara, S., Morbidelli, L., Giachetti, A., & Ziche, M. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401803 · Cited by 35
Ruzali, W. A. W., Kehoe, P. G., & Love, S. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121336 · Cited by 36
Effects of apoE isoforms on beta-amyloid-induced matrix metalloproteinase-9 in rat astrocytes
Guo, S., Wang, S., Kim, W. J., Lee, S.-R., Frosch, M. P., Bacskai, B. J., Greenberg, S. M., & Lo, E. H. (2006) · Brain Research · doi:10.1016/j.brainres.2006.06.041 · Cited by 34
Self-citationDooren, T. V., Muyllaert, D., Borghgraef, P., Cresens, A., Devijver, H., der Auwera, I. V., Wera, S., Dewachter, I., & LEUVEN, F. V. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050752 · Cited by 35
Szalárdy, L., Fakan, B., Maszlag-Török, R., Ferencz, E., Reisz, Z., Radics, B., Csizmadia, S., Szpisjak, L., Annus, Á., Zádori, D., et al. (2023) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12946 · Cited by 33
“Though being significantly lower than the treatment effect, the spontaneous clinical remission rate was considerably high at this relatively low untreated subject number (30.8% [4/13]; p = 0.0007 vs treated [Tables S3 and S4]).”
BackgroundResultInfluentialWalker, L., Simpson, H., Thomas, A. J., & Attems, J. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01714-7 · Cited by 35
Apolipoprotein E Genetic Testing in a New Age of Alzheimer Disease Clinical Practice
Ritchie, M., Sajjadi, S. A., & Grill, J. D. (2024) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000200230 · Cited by 32
Cortical superficial siderosis progression in cerebral amyloid angiopathy
Pongpitakmetha, T., Fotiadis, P., Pasi, M., Boulouis, G., Xiong, L., Warren, A. D., Schwab, K. M., Rosand, J. M., Gurol, M. E., Greenberg, S. M., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009321 · Cited by 31
Self-citationChristoforidis, M., Schober, R., & Krohn, K. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00614.x · Cited by 30
Treatment Targets in Intracerebral Hemorrhage
Sangha, N. S., & Gonzales, N. R. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0055-z · Cited by 30
“Individuals who have both alleles have an earlier onset of disease and an increased risk of recurrence [16, 21, 23].”
(ADNI), T. A. D. N. I., Valant, V., Keenan, B. T., Anderson, C. D., Shulman, J. M., Devan, W. J., Ayres, A. M., Schwab, K. M., Goldstein, J. N., Viswanathan, A., et al. (2012) · Translational Stroke Research · doi:10.1007/s12975-012-0161-1 · Cited by 30
Self-citationACE variants and risk of intracerebral hemorrhage recurrence in amyloid angiopathy
Domingues‐Montanari, S., Hernández‐Guillamón, M., Fernández‐Cadenas, I., Mendióroz, M., Boada, M., Munuera, J., Rovira, À., Maisterra, O., Parés, M., Gutierrez, M., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.01.019 · Cited by 31
Smith, E. E., Rosand, J. M., & Greenberg, S. M. (2006) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2006.06.002 · Cited by 29
Self-citationCharidimou, A., Boulouis, G., Fotiadis, P., Xiong, L., Ayres, A. M., Schwab, K. M., Gurol, M. E., Rosand, J. M., Greenberg, S., & Viswanathan, A. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-316368 · Cited by 29
Self-citationMaiti, T. K., Konar, S. K., Bir, S. C., Kalakoti, P., Bollam, P., & Nanda, A. (2015) · Neurosurgical FOCUS · doi:10.3171/2015.8.focus15329 · Cited by 28
Lamar, M., Yu, L., Rubin, L. H., James, B. D., Barnes, L. L., Farfel, J. M., Gaiteri, C., Buchman, A. S., Bennett, D. A., & Schneider, J. A. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.08.007 · Cited by 27
ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy
Montañola, A., de Retana, S. F., López‐Rueda, A., Merino-Zamorano, C., Peñalba, A., Fernández‐Álvarez, P., Rodríguez‐Luna, D., Malagelada, A., Pujadas, F., Montaner, J., et al. (2015) · NeuroMolecular Medicine · doi:10.1007/s12017-015-8381-7 · Cited by 29
“Thus, it is believed that the APOE4 allele increases the severity of vascular amyloid deposition, whereas the APOE2 appears to cause increased vasculopathic changes that lead to vessel rupture (Greenberg et al. 1998).”
Genetics and Epigenetics of Spontaneous Intracerebral Hemorrhage
Steinhauer, E. G., Jiménez-Baladó, J., Pérez, I. F., Rey-Álvarez, L., Rodríguez-Campello, A., Ois, Á., Cuadrado‐Godia, E., Jiménez-Conde, J., & Roquer, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126479 · Cited by 26
Mendel, T. A., Wierzba‐Bobrowicz, T., Lewandowska, E., Stępień, T., & Szpak, G. M. (2013) · Polish Journal of Pathology · doi:10.5114/pjp.2013.39334 · Cited by 27
“β-amyloid may originate from blood, from perivascular space or from cerebrospinal fluid, or may be produced by smooth muscle cells and by neurons [11, 27-31].”
BackgroundLonger term stroke risk in intracerebral haemorrhage survivors
Banerjee, G., Wilson, D., Ambler, G., Hostettler, I. C., Shakeshaft, C., Cohen, H., Yousry, T. A., Salman, R. A., Lip, G. Y. H., Houlden, H., et al. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-323079 · Cited by 25
Treatment and Prevention of Primary Intracerebral Hemorrhage
Towfighi, A., Greenberg, S. M., & Rosand, J. M. (2005) · Seminars in Neurology · doi:10.1055/s-2005-923538 · Cited by 25
Self-citationMastaglia, F. L., Byrnes, M. L., Johnsen, R. D., & Kakulas, B. A. (2003) · Journal of Clinical Neuroscience · doi:10.1016/s0967-5868(02)00317-x · Cited by 26
Apolipoprotein E genotype influences spatial distribution of cerebral microbleeds
Loehrer, E. A., Ikram, M. A., Akoudad, S., Vrooman, H. A., van der Lugt, A., Niessen, W. J., Albert Hofman, D., & Vernooij, M. W. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.012 · Cited by 24
Studies on the first described Alzheimer's disease amyloid β mutant, the Dutch variant
Levy, E., Prelli, F., & Frangione, B. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s337 · Cited by 24
The Pattern and Pace of Hyperacute Hemorrhage Expansion
Edlow, B. L., Bove, R. M., Viswanathan, A., Greenberg, S. M., & Silverman, S. B. (2012) · Neurocritical Care · doi:10.1007/s12028-012-9738-5 · Cited by 23
“Given that the apolipoprotein E e2 allele is associated with amyloid-related vasculopathy [15], this finding suggests that the neuroanatomic distribution of fragile, amyloid-laden vessels may play a role in determining the temporal and spatial dynamics of secondary vessel rupturing during hemorrhage expansion.”
Self-citationBrand, C., Alber, B., Fladung, A.-K., Knauer, K., König, R., Oechsner, A., Schneider, I. L., Tumani, H., Widder, B., Wirtz, C. R., et al. (2013) · British Journal of Neurosurgery · doi:10.3109/02688697.2013.815314 · Cited by 22
Genetic Animal Models of Cerebral Vasculopathies
Lee, J. H., Bacskai, B. J., & Ayata, C. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394596-9.00002-0 · Cited by 21
Current Management and Therapeutic Strategies for Cerebral Amyloid Angiopathy
Inoue, Y., Ando, Y., Misumi, Y., & Ueda, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083869 · Cited by 23
“Inasmuch as the APOE-ε2 genotype is also associated with fiprobrinoid necrosis in CAA [116,117], possession of the APOE-ε2 genotype may be related to the loss of structural integrity of the cerebrovasculature.”
BackgroundIntracerebral Hemorrhage Genetics
Ekkert, A., Šliachtenko, A., Utkus, A., & Jatužis, D. (2022) · Genes · doi:10.3390/genes13071250 · Cited by 20
Yamada, Y., Sakuma, J., Takeuchi, I., Yasukochi, Y., Kato, K., Oguri, M., Fujimaki, T., Horibe, H., Muramatsu, M., Sawabe, M., et al. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.2972 · Cited by 20
Jakubovic, R. Y. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00086 · Cited by 20
“…genotype does not appear sensitive or specific enough as an isolated variable to diagnose CAA in individual patients, the incidence of ∈2 or ∈4 positivity is reported as 18–20 and 17–26% in imaging and pathological studies (Greenberg et al., 1995, 1998; Nicoll et al., 1996; Premkumar et al., 1996).”
BackgroundHu, H., Wan, S., Hu, Y., Wang, Q., Li, H., & Zhang, N. (2025) · Annals of Medicine · doi:10.1080/07853890.2024.2445194 · Cited by 20
Bonaterra‐Pastra, A., de Retana, S. F., Rivas-Urbina, A., Puig, N., Benı́tez, S., Pancorbo, O., Rodríguez‐Luna, D., Pujadas, F., Freijo, M. D. M., Tur, S., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9010072 · Cited by 21
Nie, H., Hu, Y., Liu, N., Ping, Z., Li, G., Li, Y., Pan, C., Yu, H., Wu, Q., Wu, G., et al. (2019) · Current Medical Science · doi:10.1007/s11596-019-2007-5 · Cited by 17
García, C., Melo, T. P. E., Rocha, L., & Lechner, M. C. (1999) · Journal of Neurology · doi:10.1007/s004150050463 · Cited by 16
Smooth muscle cells and the pathogenesis of cerebral microvascular disease (“angiomyopathies”)
Auerbach, I. D., Sung, S. H., Wang, Z., & Vinters, H. V. (2003) · Experimental and Molecular Pathology · doi:10.1016/s0014-4800(03)00013-3 · Cited by 16
Coexistence of Cerebral Microbleeds and Amyloid Pathology in Patients with Cognitive Complaints
Lim, E. Y., Ryu, S. Y., Shim, Y. S., Yang, D. W., & Cho, A.-H. (2020) · Journal of Clinical Neurology · doi:10.3988/jcn.2020.16.1.83 · Cited by 15
Genetics of intracerebral haemorrhage: a tsunami effect of APOE ɛ2 genotype on brain bleeding size?
Montaner, J. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70157-0 · Cited by 14
APOE Genotype in Relation to Sporadic and Alzheimer-Related CAA
McCarron, M. O., & Nicoll, J. A. R. (2000) · Springer eBooks · doi:10.1007/978-94-017-1007-7_5 · Cited by 14
Intracerebral hemorrhage following mild ARIA-H in an APOE ε2 carrier receiving lecanemab
Ji, S.-M., & Rosenbloom, M. H. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01640-3 · Cited by 13
APOE polymorphisms influence longitudinal lipid trends preceding intracerebral hemorrhage
Phuah, C., Raffeld, M. R., Ayres, A. M., Gurol, M. E., Viswanathan, A., Greenberg, S. M., Biffi, A., Rosand, J. M., & Anderson, C. D. (2016) · Neurology Genetics · doi:10.1212/nxg.0000000000000081 · Cited by 13
Self-citationHereditary and sporadic beta-amyloidoses
Fede, G. D. (2013) · Frontiers in bioscience · doi:10.2741/4173 · Cited by 13
Chapter 38 Intracerebral hemorrhage
Viswanathan, A., & Greenberg, S. M. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(08)93038-4 · Cited by 13
Self-citationGreenberg, S. M. (2004) · Elsevier eBooks · doi:10.1016/b0-44-306600-0/50039-0 · Cited by 13
Self-citationBonaterra‐Pastra, A., Benítez, S., Pancorbo, O., Rodríguez‐Luna, D., Vert, C., Rovira, À., Freijo, M. D. M., Tur, S., Martínez-Zabaleta, M., Portela, P. C., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1134399 · Cited by 11
Chen, Y.-C., Lee‐Chen, G., Wu, Y., Hu, F.-J., Wu, H.-C., Kuo, H., Chu, C., Ryu, S., Chen, S., & Chen, C. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.08.004 · Cited by 11
“The role of apolipoprotein E (APOE) gene in lobar SICH has been reported and replicated in multiple ethnicities [15–22], in which both the ε2 and ε4 alleles are implicated in the CAA-related vascular damage.”
BackgroundCantara, S., Ziche, M., & Donnini, S. (2005) · PubMed · Cited by 11
Silbert, L. C. (2024) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001508 · Cited by 11
Contemporary perspectives in cerebral amyloid angiopathy
Sellimi, A., Schwartze, J., Humphries, F., Panteleienko, L., Mallon, D. H., Banerjee, G., & Werring, D. J. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2526113 · Cited by 10
The Neuropathologic Substrates of Vascular-Ischemic Dementia
Jellinger, K. A. (2005) · Humana Press eBooks · doi:10.1385/1-59259-824-2:023 · Cited by 10
Cerebral Amyloid Angiopathy with Severe Secondary Vascular Pathology: A Histopathological Study
van Horssen, J., de Jong, D., de Waal, R. M. W., Maass, C., Otte‐Höller, I., Kremer, B. P. H., Verbeek, M. M., & Wesseling, P. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000088462 · Cited by 10
Carhuapoma, J. R., Mayer, S. A., & Hanley, D. F. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511691836.002 · Cited by 9
A case of amyloid-β-related cerebral angiitis with ApoE ε4/ε2 genotype
Ogura, A., Moriyoshi, H., Nakai, N., Nishida, S., Kitagawa, S., Yoshida, M., Yasuda, T., & Ito, Y. (2015) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-000685 · Cited by 9
Post-Stroke Cognitive Impairment
Patel, B. B., & Birns, J. (2015) · Springer eBooks · doi:10.1007/978-3-319-17855-4_12 · Cited by 9
“Haemorrhages caused by amyloid angiopathy are typically lobar and at the border of grey and white matter of the cerebral hemispheres [ 31 ].”
BackgroundLee, J. S., Lee, H., Park, S., Choe, Y. S., Park, Y. H., Cheon, B. K., Hahn, A., Ossenkoppele, R., Kim, H. J., Kim, S., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010811 · Cited by 8
Apolipoprotein E genotype predicts subarachnoid extension in spontaneous intracerebral haemorrhage
Ye, X., Guo, L., Liu, X., Song, G., Jia, Y., Wu, C., Wang, X., Huang, S., & Zhu, S. (2021) · European Journal of Neurology · doi:10.1111/ene.14830 · Cited by 8
Genetic aspects of microangiopathy-related cerebral damage
Schmidt, H., Fazekas, F., Kostner, G. M., & Schmidt, R. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6781-6_3 · Cited by 8
Genetics of primary intracerebral hemorrhage
Greenberg, S. M. (2002) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1053/jscd.2002.129615 · Cited by 8
Self-citationBonaterra‐Pastra, A., Solé, M., Lope‐Piedrafita, S., Lucas-Parra, M., Castellote, L., Marazuela, P., Pancorbo, O., Rodríguez‐Luna, D., & Hernández‐Guillamón, M. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01541-5 · Cited by 7
Multiple ischemic strokes in a patient treated with Lecanemab: a case report
Alammar, H., Diallo, M., & Llano, D. A. (2025) · Neurocase · doi:10.1080/13554794.2025.2566151 · Cited by 7
“Finally, this patient had one copy of the apoli-poprotein E2 allele, and the presence of this allele has been associated with type 2 CAA and lobar hemorrhage (Greenberg et al., 1998; Nicoll et al., 1997; Thal et al., 2002).”
What Caused This Intracerebral Haemorrhage?
Warlow, C., van Gijn, J., Dennis, M. S., Wardlaw, J. M., Bamford, J., Hankey, G. J., Sandercock, P. A., Rinkel, G. J. E., Langhorne, P., Sudlow, C. L. M., et al. (2008) · Stroke · doi:10.1002/9780470696361.ch8 · Cited by 7
Mouse models of Anti-Aβ immunotherapies
Pikus, P., Turner, R. S., & Rebeck, G. W. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00836-x · Cited by 6
Self-citationRodrigues, M. A., Seiffge, D. J., Samarasekera, N., Moullaali, T. J., Wardlaw, J. M., Schreiber, S., Behymer, T. P., Khandwala, V. J., Stanton, R. J., Vagal, V. S., et al. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00285-6 · Cited by 6
Self-citationYin, C., Ruan, J., Jiang, L., Zhou, S., & Sun, X. (2012) · International Journal of Neuroscience · doi:10.3109/00207454.2012.678445 · Cited by 6
Murthy, S. B., Jawaid, A., Qureshi, S. U., Schulz, P. E., & Schulz, P. E. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02284.x · Cited by 4
Jin, Y., Huang, Y., Chen, Y., Zhang, Y. J., Li, J., Yang, K.-C., Ye, X., Jin, L., Wu, J., Yuan, C.-Z., et al. (2023) · Stroke and Vascular Neurology · doi:10.1136/svn-2023-002439 · Cited by 5
Incident Dementia After Spontaneous Intracerebral Hemorrhage
Zhang, Z.-T., & Lim, M. J. R. (2024) · Journal of Alzheimer's Disease · doi:10.3233/jad-240111 · Cited by 3
“These alleles were shown to increase cerebral vascular amyloid deposition, concentric vessel splitting and fibrinoid necrosis, predisposing to vessel rupture [83].”
Rost, N. S. (2013) · Neurologic Clinics · doi:10.1016/j.ncl.2013.05.001 · Cited by 5
L’angiopathie amyloïde cérébrale
Roch, J. A., Hermier, M., Jouvet, A., & Nighoghossian, N. (2007) · Revue Neurologique · doi:10.1016/s0035-3787(07)90366-5 · Cited by 5
Update on Amyloid-associated Intracerebral Haemorrhage
Grysiewicz, R. A., & Gorelick, P. B. (2012) · European Neurological Review · doi:10.17925/enr.2012.07.01.22 · Cited by 5
Gurol, M. E., & Greenberg, S. M. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316551684.068 · Cited by 5
Self-citationClinical Aspects and Diagnostic Criteria of Sporadic CAA-Related Hemorrhage
Greenberg, S. M. (2000) · Springer eBooks · doi:10.1007/978-94-017-1007-7_1 · Cited by 5
Self-citationCognitive impairment, aphasia, and seizures in a 51-year-old man
Kern, R., Kreisel, S. H., Zoubaa, S., Szabo, K., Gass, A., & Hennerici, M. G. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70122-8 · Cited by 5
Angiopathie amyloïde cérébrale sporadique
Cabrejo, L., Chassagne, P., Doucet, J., Laquerrière, A., Puech, N., & Hannequin, D. (2006) · Revue Neurologique · doi:10.1016/s0035-3787(06)75118-9 · Cited by 5
Classification, pathology, and basic aspects
Pantoni, L., & Gorelick, P. B. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139382694.002 · Cited by 5
Incidence of Convexal Subarachnoid Hemorrhage in the Elderly: The Mayo Clinic Study of Aging
Yost, M. D., Fiebelkorn, C. A., Rabinstein, A. A., Klaas, J. P., Aakre, J. A., Brown, R. D., Mielke, M. M., Knopman, D. S., Lowe, V. J., Petersen, R. C., et al. (2019) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2019.104451 · Cited by 4
COVID-19-related vasculopathy of the brain
Liang, H., Mung, S. M., Douglass, C., & Jude, E. B. (2021) · BMJ Case Reports · doi:10.1136/bcr-2021-242028 · Cited by 4
Apolipoprotein E Alleles and Motor Signs in Older Adults with Alzheimer’s Dementia
Liampas, I., Demiri, S., Siokas, V., Tsika, A., Marogianni, C., Stamati, P., Nasios, G., Messinis, L., Lyketsos, C. G., & Dardiotis, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178562 · Cited by 3
“Although APOE2 protects against plaque A β , it is related to increased CAA [32,33].”
Greenberg, S. M. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511691836.005 · Cited by 3
Self-citationWang, S., Ye, Q., & Lü, X. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0821-6 · Cited by 3
Zhang, Q., Zeng, L., Chen, X., Zhou, Y., Gong, B., Li, H., & Guo, J. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/3120179 · Cited by 3
Hemorragia encefálica por angiopatía amiloidea
Tapia, J. F. (2021) · Revista médica de Chile · doi:10.4067/s0034-98872021000100076 · Cited by 3
Ikeda, M., Okamoto, K., Suzuki, K., Takai, E., Kasahara, H., Furuta, N., Furuta, M., Tashiro, Y., Shimizu, C., TAKATAMA, S., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.645625 · Cited by 3
Cerebral microbleeds: Spatial distribution implications
Loehrer, E. A., Vernooij, M. W., & Ikram, M. A. (2014) · Translational Neuroscience · doi:10.2478/s13380-014-0217-7 · Cited by 3
Mendel, T. A., & Gromadzka, G. (2010) · Neurologia i Neurochirurgia Polska · doi:10.1016/s0028-3843(14)60157-2 · Cited by 3
Metadata
- Authors
- Greenberg, S. M., Vonsattel, J.-P. G., Segal, A. Z., Chiu, R. I., Clatworthy, A. E., Liao, A., Hyman, B. T., & Rebeck, G. W.
- Affiliations
- Harvard University (US)
- Venue
- Neurology
- Published
- 1998-04
- Volume
- 50
- Issue
- 4
- Pages
- 961-965
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2041396523
- Cited by
- 267
- References
- 23
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 11 · 2023: 6 · 2022: 6 · 2021: 10 · 2020: 8 · 2019: 11 · 2018: 12 · 2017: 9 · 2016: 4 · 2015: 15 · 2014: 9 · 2013: 15 · 2012: 12
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Chinese Academy of Agricultural Sciences
- National Institute on Aging (AG14473, AG 12406, AG00725)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Keywords
- cerebral amyloid angiopathy, APOE ε4, intracerebral hemorrhage, vasculopathy, amyloid-beta deposition, postmortem brain
- MeSH terms
- Age Factors, Aged, Aged, 80 and over, Amyloidosis, Apolipoproteins E, Cerebral Arteries, Cerebral Hemorrhage, Genotype, Humans, Middle Aged, Cohort Studies, Apolipoprotein E2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review